RogerOveMDPhD

PubMed

• Dose uncertainty due to needle-tip localization error in prostate seed implantation.
  Zhengzheng Xu, Theodore H Arsenault, Bryan Traughber, Roger Ove, Tarun K Podder> ;Journal of Contemporary Brachytherapy. 2022 Dec 1
• 1 citations
  Pattern of Radiotherapy Treatment in Low-Risk, Intermediate-Risk, and High-Risk Prostate Cancer Patients: Analysis of National Cancer Database.
  Asoke Dey, Sujay Datta, Ana Nassar, William Grubb, Bryan Traughber, Tithi Biswas, Roger Ove, Tarun Podder, Agrawal, R.> ;Cancers. 2022 Nov 9
• 20 citations
  Roles of p53, NF-κB and the androgen receptor in controlling NGAL expression in prostate cancer cell lines
  William H. Chappell, Saverio Candido, Stephen L. Abrams, Suzanne Russo, Roger Ove, Alberto M. Martelli, Lucio Cocco, Giulia Ramazzotti, Melchiorre Cervello, Giuseppe M...> ;Advances in Biological Regulation. 2018 May 18
• 4 citations
  Induction chemotherapy for head and neck cancer: is there still a role?
  Roger Ove, Lisle Nabell> ;Future Oncology. 2016 Apr 20
• Tolerance of Superficial Dose to Setup Error With Tomotherapy: Is a Skin Flash Tool Required?
  James O. Galle, Madhu B. Chilukuri, Stacey L. Buckley, Martha J. Hall, La Chandra R. Wilcox, Roger Ove> ;Technology in Cancer Research & Treatment. 2016 Jun 1
• 11 citations
  Radiotherapy in the management of pancreatic neuroendocrine tumors (PNET): experience at three institutions.
  Muhammad Wasif Saif, Roger Ove, John Ng, Suzanne Russo> ;Anticancer Research. 2013 May 1
• Hybrid intensity modulated radiotherapy - stereotactic radiosurgery for treatment of pituitary macroadenomas.
  Andrew J. Vincent, James O. Galle, Anthony Martino, Suzanne Russo, Roger Ove> ;Practical Radiation Oncology. 2013 Apr 1
• 17 citations
  Variation of neck position with image-guided radiotherapy for head and neck cancer.
  Roger Ove, Ronaldo Cavalieri, Darin Noble, Suzanne Russo> ;American Journal of Clinical Oncology. 2012 Feb 1
• 53 citations
  Emerging MEK inhibitors
  James A. McCubrey, Linda S. Steelman, Steven L. Abrams, William H. Chappell, Suzanne Russo, Roger Ove, Michele Milella, Agostino Tafuri, Paolo Lunghi, Antonio Bonati, ...> ;Expert Opinion on Emerging Drugs. 2010 May 20
• 27 citations
  Emerging Raf inhibitors.
  James A. McCubrey, Linda S. Steelman, Steven L. Abrams, William H. Chappell, Suzanne Russo, Roger Ove, Michele Milella, Agostino Tafuri, Paolo Lunghi, Antonio Bonati, ...> ;Expert Opinion on Emerging Drugs. 2009 Nov 26
• 2 citations
  Dose optimization of breast balloon brachytherapy using a stepping 192Ir HDR source.
  Chang Hyun Choi, Sung-Joon Ye, E. Ishmael Parsai, Sui Shen, Ruby F. Meredith, Ivan A. Brezovich, Roger Ove> ;Journal of Applied Clinical Medical Physics. 2009 Feb 3
• 26 citations
  Locally advanced pancreatic cancer: a review.
  Suzanne Russo, Jerome M. Butler, Roger Ove, A. William Blackstock> ;Seminars in Oncology. 2007 Aug 1
• 7 citations
  Intensity modulation with respiratory gating for radiotherapy of the pleural space.
  Raef S. Ahmed, Sui Shen, Roger Ove, Jun Duan, John B. Fiveash, Suzanne Russo> ;Medical Dosimetry. 2007 Mar 1
• 2 citations
  Doppler broadening effect on low-energy photon dose calculations using MCNP5 and PENELOPE.
  Sung-Joon Ye, Roger Ove, Shahid A. Naqvi> ;Health Physics. 2006 Oct 1
• 2 citations
  Intensity-modulated radiotherapy (IMRT) for carcinoma of the maxillary sinus: A comparison of IMRT planning systems
  Raef S. Ahmed, Roger Ove, Jun Duan, Richard A. Popple, Glenn B. Cobb> ;Medical Dosimetry. 2006 Sep 1
• 3551 citations
  Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
  James A. Bonner, Paul M. Harari, Jordi Giralt, Nozar Azarnia, Dong M. Shin, Roger B. Cohen, Christopher U. Jones, Ranjan Sur, David Raben, Jacek Jassem, Roger Ove, Mer...> ;The New England Journal of Medicine. 2006 Feb 9
• 10 citations
  Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer...
  James A. Bonner, Donald J. Buchsbaum, Buck E. Rogers, William E. Grizzle, Hoa Q. Trummell, David T. Curiel, John B. Fiveash, Roger Ove, Kevin P. Raisch> ;International Journal of Radiation Oncology, Biology, Physics. 2004 Mar 1
• 4 citations
  Molecular targets as therapeutic strategies in the management of breast cancer.
  Suzanne Russo, Roger Ove> ;Expert Opinion on Therapeutic Targets. 2003 Aug 1
• 3 citations
  Sequential annealing-gradient Gamma-Knife radiosurgery optimization.
  Roger Ove, Richard A. Popple> ;Physics in Medicine and Biology. 2003 Jul 21
• 73 citations
  Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation.
  Richard A. Popple, Roger Ove, Sui Shen> ;International Journal of Radiation Oncology, Biology, Physics. 2002 Nov 1
• 4 citations
  Standardization of prostate brachytherapy treatment plans.
  Roger Ove, Kent E. Wallner, K. A. S. Badiozamani, Tammy Korjsseon, Steven Sutlief> ;International Journal of Radiation Oncology, Biology, Physics. 2001 May 1
• 4 citations
  Identification of Prognostic and Predictive Markers in Pancreatic Adenocarcinoma
  Suzanne Russo, Roger Ove, Muhammad Wasif Saif> ;JOP. 2011 Mar 9
• Join now to see all

Journal Articles

• Standardization of Prostate Brachytherapy Treatment Plans.  
  Ove R, Wallner K, Badiozamani K, Korjsseon T, and Sutlief S., International Journal of Radiation Oncology, Biology, Physics, 50, number 1, 267-263
• Inverse Treatment Planning for Gamma Knife Radiosurgery.  
  Shepard DM, Ferris MC, Ove R, and Ma L, Medical Physics, 27, Number 12, 2748-56
• Preservation of Visual Fields after Peri-sellar Gamma-Knife Radiosurgery.  
  Ove R, Kelman S, Amin P, and Chin LS, International Journal of Cancer, 90, Number 6, 343-350
• Postoperative Endoscopic Retrograde HDR Brachytherapy for Cholangiocarcinoma.  
  Ove R, Kennedy AS, Darwin P, and Haluszka O, American Journal of Clinical Oncology, 23, Number 6, 559-61
• Tomographic Convolutional Dosimetry of Interstitial Brachytherapy Implants.  
  Ove R, Medical Physics, 26, Number 6
• Delayed expression of hpS2 and prolonged expression of CIP1/WAF1/SDI1 in human tumor cells irradiated with X-rays, fission neutrons, or 1 GeV/n Fe-ions.  
  Balcer-Kubiczek EK, Zhang XF, Harrison GH, Zhou XJ, Vigneulle RM, Ove R, McCready WA, Xu JF, Int. J. Radiat. Biol., 75, Number 5, 529-541
• Gene Therapy-induced Augmentation of Epidermal Growth Factor Receptor (EGFr) Enhances the Radiosensitization Properties of Anti-EGFr Treatment in Prostate Cancer Cells.  
  Int. J. Radiat. Biol., 75, Number 5, 529-541, International Journal of Radiation Oncology, Biology, Physics, 58, number 3, 950-958
• Intensity Modulated Radiotherapy for Carcinoma of the Maxillary Sinus.  
  Ahmed R, Ove R, Duan J, Popple R, and Cobb GB, Medical Dosimetry, 31 (3); 224-32
• New Approaches to Postoperative Radiotherapy for Cancer of the Head and Neck.  
  Prellop P and Ove R, Current Cancer Therapy Reviews, 1, number 1, 63-70
• The Multidisciplinary Treatment of Non-Metastatic Pancreatic Cancer: A Review.  
  Russo S, Ove R, Blackstock AW, Cancer Therapy, 6: 341-357
• Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Pathways: Therapeutic Targets for Controlling Cancer Growth.  
  McCubrey JA, Steelman LS, Abrams SL, Chappell WH, Russo S, Ove R, Milella M, Tafuri A, Lunghi P, Bonati A, Stivala F, Nicoletti F, Libra M, Martelli AM, Montalto G, C..., Expert Opin Emerg Drugs
• Variation of Neck Position with Image Guided Radiotherapy for Head and Neck Cancer  
  Ove R, Calavieri R, Noble D, Russo S, Am J Clin Oncol. 35 (1): 1-5
• Identification of Prognostic and Predictive Markers in Pancreatic Adenocarcinoma: 2011 ASCO Gastrointestinal Cancer Symposium.  
  Russo SM, Ove R, Saif MW, JOP, 12 (2); 92-95
• Adjuvant Trials for Pancreatic Cancer: Where Are We Going and What is Needed?  
  Russo S, Ove R, Saif MW, Clinical Investigation, 1 (5); 661-667
• Anomalous Foliations of Einstein Space-times.  
  Ove R, Journal of Mathematical Physics, 31, Number 11, 2688
• Analysis of Cosmological Gravitational Wave Residue.  
  Ove R, Classical and Quantum Gravity, 7, 2225
• Analysis of Cosmological Gravitational Wave Residue.  
  Ove R, Classical and Quantum Gravity, 7, 2225
• Anisotropic Effective Core Potentials.  
  Sellers H and Ove R, Chemical Physics Letters, 170, 523
• Nonlinear Gravitational Effect.  
  Ove R, Physical Review Letters, 64, Number 11, 1200
• Properties of a Model Einstein Equation.  
  Ove R, General Relativity and Gravitation, 22, Number 6, 631
• Properties of a Model Einstein Equation.  
  Ove R, General Relativity and Gravitation, 22, Number 6, 631
• Symmetry and Singularity Formation in Expanding Spacetimes.  
  Ove R, Physical Review D
• Instability of the Kerr Solution of Fourth Order Gravity.  
  Hersh J and Ove R, Physics Letters, 156B, 305
• Instability of Some Black Holes  
  Detweiler S and Ove R, Physical Review Letters, 51, Number 67
• Pulse-Reduced Dose Rate for the Retreatment of Recurrent Head and Neck Cancer.  
  Russo S. and Ove R, Mitchell Cancer Institute Research Symposium
• Join now to see all

Books/Book Chapters

• Novel Anticancer Agents, Strategies for Discovery and Clinical Testing. 
  Chapter: Molecular Targets for Radiosensitization 
  Page 391 - 414Ove R and Bonner JAEditors: Adjei AA and Buolamwini JK.Elsevier Academic Press
• Clinical Radiation Oncology. 
  Chapter: Nasopharyngeal Carcinoma 
  Ove R, Foote RL, and Bonner JAEditors: Gunderson LL and Tepper JE.Elsevier Churchill LivingstoneEdition 2,
• Radiation Oncology: An Evidence-Based Approach. 
  Chapter: Thyroid Cancer 
  Ove R and Allison RREditors: Lu JJ and Brady LW.Springer
• Nasopharyngeal Cancer- Multidisciplinary Management. 
  Chapter: Early Stage Nasopharyngeal Cancer: A Highly Curative Disease with Radiation Therapy 
  Ove R, Allison RR, and Lu JJEditors: Lu JJ and Brady LW.Springer
• Radiation Oncology: An Evidence-Based Approach. 
  Chapter: Thyroid Cancer 
  Ove R and Drake AEditors: JJ and Brady LW.Springer
• Adverse Radiation Effects on the Pancreas in Adverse Late effects of Radiation Treatment (ALERT). 
  Russo S, Ove R, Fajardo L, Tepper JEditors: Philip Rubin, Louis Constine, Larry Marks, Laura Dawson, Debra Friedma0n, Zeljko Vujaskovic ......WB Saunders
• Clinical Radiation Oncology. 
  Chapter: Nasopharyngeal Carcinoma 
  Lee N, Laufer M, Ove R, Foote RL, and Bonner JAEditors: Gunderson LL and Tepper JE.Elsevier Churchill LivingstoneEdition 3,
• Frontiers of Numerical Relativity. 
  Chapter: An Algorithmic Overview of an Einstein Solver 
  Ove REditors: Evans, Finn, & Hobill.Cambridge University Press
• Dynamical Spacetimes and Numerical Relativity. 
  Chapter: Numerical Investigations of Cosmic Censorship on T3xR 
  Ove REditors: J. Centrella.Cambridge University Press
• Join now to see all

Abstracts/Posters

• Multi-centre Clinical Assessment of Auto-contouring using Deformable Image Registration for Adaptive Therapy.
  Gooding MJ, Conibear J, Dilling T, Fuss M, Gujral D, Ove R, Stevens C, Kadir T, ASTRO. Altlanta
• Multi-centre clinical assessment of atlas-based contouring. ASTRO.
  Gooding MJ, Conibear J, Dilling T, Fuss M, Gujral D, Ove R, Stevens C, Kadir T, Atlanta
• Hybrid Cyberknife/IMRT Radiotherapy for Pituitary Macroadenoma.
  Galle J., Vincent A., Russo S., Martino A., Ove R, RSNA. Chicago Ill
• Pulse-Reduced Dose Rate for the Retreatment of Recurrent Head and Neck Cancer.
  Russo S. and Ove R, ASTRO Head and Neck Symposium. Phoenix Arizona
• Hypofractionation Approaches in Radiation Therapy.
  R. Ove, Oncology Outlook, Point Clear, Alabama
• Selective Neck IMRT for Locally Advanced Head and Neck Carcinoma.
  R. Ove, M. E. Couch, P. S. Camnitz, S. M. Russo, D. Noble, J. G. Rosenman, RSNA, Chicago
• UAB-0210: A Phase I/II trial of induction chemotherapy followed by concomitant docetaxel/radiotherapy with subcutaneous amifostine for advanced squamous cell carcinoma...
  Nabell L, Peters G, Meredith R, Carroll W, Bonner J, Ove R, Spencer S, ASCO
• Variation of Neck Position with Image Guided Radiotherapy for Head and Neck Cancer.
  Ove R. Cavalieri R, ASTRO, Boston MA
• Intensity-Modulated and Image-Guided Radiation therapy (IMRT/IGRT) Salvage for Rising Post-Prostatectomy PSA: Outcomes and Morbidity.
  Allison R, Dairkee, U, Gay H, Ove R, Frelix G, Arastu H, Murphy G, ASTRO, Boston MA
• Cox-2 inhibition and chemoradiation for squamous cell carcinoma of the head and neck.
  Spencer S, Nabell L, Bonner J, Peters G, Carroll WL, Meredith R, Clemons L, Ove R, ASCO
• Induction Chemotherapy followed by Concomitant Docetaxel with Concomitant Boost Radiotherapy (CBR) for Cancer of the Head and Neck.
  Prellop P, Ove R, Meredith R, Bonner JA, Peters G, Carroll W, Spencer SA, Nabell L, ASCO
• The relationship of Cetuximab-induced rash and survival in patients with head and neck cancer treated with radiotherapy and cetuximab.
  Bonner JA, Harari PM, Giralt J, Cohen R, Baselga J, Raben D, Shin DM, Ove R, Jassem J, Amellal N, Azarnia N, Ang KK, American Society for Therapeutic Radiology and Oncology
• Radiosensitization with a Cox-2 inhibitor, with Chemoradiation for Cancer of the Head and Neck.
  George J, Peters G, Carroll W, Nabell L, and Ove R, Proceedings of the American Society of Clinical Oncology (ASCO)
• Dose Non-Uniformity on Prescription Surface and Skin for Balloon Catheter Brachytherapy for Breast Cancer.
  Ye S, Ove R, Kim S, Shen S, Duan J, and Brezovich I, American Association of Physics in Medicine
• Dose Overestimation in Balloon Catheter Brachytherapy for Breast Cancer.
  Ye S, Ove R, Shen S, Russo S, and Brezovich I, American Society for Therapeutic Radiology and Oncology
• Radiation Tolerance of the Optic Apparatus.
  Cook B, Withrow LA, Spencer SA, Ove R, and Fiveash JB, American Society for Therapeutic Radiology and Oncology
• Regional nodal failure in squamous cell carcinoma of the nasal cavity.
  Prellop P, Ove R, and Peters G, American Society for Therapeutic Radiology and Oncology
• Combination Radiation and Epidermal Growth Factor Receptor Blockade in Head and Neck Cancer.
  Bonner JA, Raisch KP, Buchsbaum DJ, Giralt J, Ove R, Spencer SA, Azamia N, Robert F, Chemotherapy Foundation Symposium XXII, New York, Cancer Investigation, 23
• Evaluation of the PSMA Promoter for use in a Conditionally Replicative Adenovirus (CRAd).
  Ove R, Swift A, Nettlebeck DM, Yamamato M, Krasnykh VN, and Curiel DT, Radiation Research Society, Brisbane Australia
• Join now to see all